Synthesis and anticonvulsant activity of 2(3H)-benzoxazolone and 2(3H)- benzothiazolone derivatives

Journal of Medicinal Chemistry

Volumn 41, Issue 7, 1998, Pages 1138-1145

  Ucar, Huseyin ^a   Van Derpoorten, Kim ^a   Cacciaguerra, Silvia ^b   Spampinato, Santi ^b   Stables, James P ^c   Depovere, Paul ^a   Isa, Majed ^a   Masereel, Bernard ^d   Delarge, Jacques ^d   Poupaert, Jacques H ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^d UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

2 BENZOXAZOLONE DERIVATIVE; 6 METHOXY 2 BENZOXAZOLINONE; ANTICONVULSIVE AGENT;

ANIMAL EXPERIMENT; ANTICONVULSANT ACTIVITY; ARTICLE; DRUG DETERMINATION; DRUG EFFICACY; DRUG SYNTHESIS; EPILEPSY; EPILEPTIC DISCHARGE; LIGAND BINDING; MOUSE; NONHUMAN; PLANT; RAT; RECEPTOR AFFINITY; RECEPTOR BINDING;

ANIMALS; ANTICONVULSANTS; ELECTRIC STIMULATION; INJECTIONS, INTRAPERITONEAL; MALE; MICE; OXAZOLES; RATS; SEIZURES; THIAZOLES;

EID: 15644379603     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm970682+     Document Type: Article

References (43)

1. Guelen, P. J. M.; Van der Kleijn, E. Rational Anti-Epileptic Drug Therapy; Elsevier: Amsterdam, 1978; p 1.
2. Hauser, W. A.; Kurland, L. T. The epidemiology of epilepsy in Rochester, Minnesota, 1935 through 1967. Epilepsia 1975, 16, 1-66.
3. Eadie M. J. Anticonvulsant drugs: An update. Drugs 1984, 27, 328-363.
4. Eadie M. J. "the Treatment of Epilepsy"; Tyrer J. H. Ed.; MTP Press Lancaster 1980, 129.
5. Leppik, I. E. Antiepileptic drugs in development: prospects for the near future. Epilepsia 1994, 35, S29-40.
6. Brodie, J. M. Lamotrigine. Lancet 1992, 339, 1397-1400.
7. Wagner, M. L. Felbamate: a new antiepileptic drug. Am. J. Hosp. Pharm. 1994, 51, 1657-1666.
8. Swinyard, E. A.; Sofia, R. D.; Kupferberg, H. J. Comparative anticonvulsant activity and neurotoxicity of felbamate and four prototype antiepileptic drugs in mice and rats. Epilepsia 1986, 27, 27-34.
9. Sweat, F. W.; Berger, P. J. Uterotropic 6-methoxybenzoxazolinone is an adrenergic agonist and a melatonin analogue. Mol. Cell. Endocrinol. 1988, 57, 131-138.
10. Sanders, E. H.; Gardner, P. D.; Berger, P. J.; Negus, N. C. 6-Methoxybenzoxazolinone: A plant derivative that stimulates reproduction in Microtus montanus. Science 1981, 214, 67-69.
11. Groenwick. Bull. Soc. Chim. 1876, 25 (2), 178.
12. Kolasa, K.; Kleinrok, Z. Central effects of new acyl and aminomethyl derivatives of benzoxazol-2-one. Acta Pol. Pharm. 1979, 36, 383-391.
13. Paskov, D.; Bakurdzhiev, A.; Kalcheva, V.; Simov, D.; Kamenova, L.; Boicheva, K. H. Pharmacological activity of benzoxazolones. Farmatsiya 1975, 25, 61-74.
14. Turk, C. F.; Krapcho, J.; Michel, T. M.; Weinryb, I. Synthesis and central nervous system of 2-arylidene-4-aminoalkyl-2H-1,4-benzoxazin-3(4H)-ones and related compounds. J. Med. Chem. 1977, 20, 729-732.
15. Orcutt, J. A.; Prytherch, J. B.; Konikov, M.; Michaelson, S. M. Some new compounds exhibiting selective central nerve depressant activities. I. Preliminary observations. Arch. Int. Pharmacodyn. 1964, 152, 121-131.
16. Bonte, J. P.; Lesieur, D.; Lespagnol, C.; Plat, M.; Cazin, J. C.; Cazin, M. 6-Acyl-benzoxazolinones. Eur. J. Med. Chem. 1974, 9, 491-496.
17. Lesieur, D.; Aichaoui, H.; Lespagnol, C.; Bonnet, J. Nouveaux dérivés d'acyl-5 benzoxazolinones, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent. French Patent 89-04129, 1989.
18. Tacquet, A.; Lespagnol, C.; Beerens, H.; Lesieur, D.; Devulder, B. Antimicrobial activity of derivates of benzoxazolinone. Ann. Inst. Pasteur Lille 1971, 22, 189-200.
19. Moussavi, Z.; Plancke, M. O.; Olivier, P.; Lesieur, D.; Fruchart, J. C.; Sauzieres, J. Lipid lowering actions of 7-(2-methylene butyryl)-(2H)-1,4-benzoxazin-3(4H)-one derivatives in mice, rats and Syrian hamsters. Clin. Chim. Acta 1989, 780, 35-44.
20. Aichaoui, H.; Poupaert, J. H.; Lesieur, D.; Hénichart, J.-P. Regioselectivity in the C-Acylation of 2(3H)-Benzoxazolones. Tetrahedron 1991, 47, 6649-6654.
21. Vaccher, M. P.; Lesieur, D.; Lespagnol, C.; Bonte, J. P.; Lamar, J. C.; Beaughard, M.; Dureng, G., II Benzoxazolinone phenylethanolamine antagonists of adrenergic receptors: A chemical and pharmacodynamic study. Farm. Ed. Sci. 1986, 41, 257-269.
22. 1A receptors. Heterocycles 1995, 41, 1219-1233.
23. 3 affinities. Eur. J. Med. Chem. 1995, 30, 715-719.
24. Dalkara, S.; Calis, U.; Sunal, R. Synthesis and anticonvulsant activity of some new 2(3H)-benzoxazolone derivatives. J. Pharm. Belg. 1988, 43 (5), 372-378.
25. 3-DMF reagent in the Friedel-Crafts reaction. Application to the synthesis of symmetrical benzophenone derivatives. Heterocycles 1997, 45, 805-810.
26. Ucar, H.; Van derpoorten, K.; Kanyonyo, M.; Isa, M.; Lambert, D.; Lesieur, D.; Poupaert, J. H. Synthesis of 6-benzoyl-2(3H)-benzoxazolone and 6-benzoyl-2(3H)-benzothiazolone. Bull. Soc. Chim. Belg. 1996, 105, 773-776.
27. Ucar, H.; Van derpoorten, K.; Depovere, P.; Lesieur, D.; Isa, M.; Masereel, B.; Delarge, J.; Poupaert, J. H. "Fries-like" rearrangement: A novel and efficient method for the synthesis of 6-acyl-2(3H)-benzoxazclones and 6-acyl-2(3H)-benzothiazolones. Tetrahedron 1998, 54, 1763-1772.
28. Aichaoui, H.; Lesieur, D.; Hénichart, J. P. A convenient and efficient method for the preparation of 6-acyl-2(3H)-benzoxazolones. J. Heterocycl. Chem. 1992, 29, 171-175.
29. West, C. T.; Donnelly, S. J.; Kooistra, D. A.; Doyle, M. P. Silane reduction in acidic media. II. Reductions of aryl aldehydes and ketones by trialkylsilanes in trifluoroacetic acid. A selective method for converting the carbonyl group to methylene. J. Org. Chem. 1973, 38, 2675-2681.
30. Anticonvulsant Screening Project, Antiepileptic Drug Development Program, National Institutes of Health, DHEW Publ (NIH), 1978; NIH 78-1093.
31. Porter, R. J.; Cereghino, J. J.; Gladding, G. D.; Hessie, B. J.; Kupferberg, H. J.; Scoville, B.; White, B. G. Antiepileptic drug development program. Cleveland Clin. Q. 1984, 51, 293-305.
32. Krall, R. L.; Penry, J. K.; White, B. G.; Kupferberg, H. J.; Swinyard, E. A. Antiepileptic drug development: II. Anticonvulsant drug screening. Epilepsia 1978, 19, 409-428.
33. Swinyard, E. A.; Woodhead, J. H.; White, H. S.; Franklin, M. R. General Principles-Experimental section, quantification and evaluation of anticonvulsants. Antiepileptic Drugs, 3rd ed.; Raven Press: New York, 1989; pp 85-102.
34. Litchfield, J. T.; Wilcoxon, E. A. A simplified method of evaluating dose-effect experiments. J. Pharmacol. Exp. Ther. 1949, 96, 99-104.
35. 1 receptor ligands. Eur. J. Pharmacol. 1997, 355, 267-273.
36. Feringa, B.; Wynberg, H. Biomimetic asymmetric oxidative coupling of phenols. Bioorg. Chem. 1978, 7, 397-408.
37. Walker, J. M.; Bowen, W. D.; Walker, F. O.; Matsumoto, R. R.; De Costa, B.; Rice, K. C. Sigma receptors: Biology and function. Pharmacol. Rev. 1990, 42, 355-402.
38. 3H]-3-PPP label pharmacologically distinct σ binding sites in guinea pig brain membranes. Eur. J. Pharmacol. 1991, 193, 21-27.
39. Tortella, F. C.; Witkin, J. M.; Musacchio, J. M. Caramiphen: A non-opioid antitussive with potent anticonvulsant properties in rats. Eur. J. Pharmacol. 1988, 155, 69-75.
40. Kaiser, C.; Pontecorvo, J.; Mewshaw, R. Sigma receptor ligands: Function and activity. Neurotransmissions 1991, 7, 1-22.
41. 1 site. J. Neurosci. 1995, 15, 731-736.
42. 2+ channels in rat and mouse cultured hippocampal pyramidal neurones. Br. J. Pharmacol. 1995, 116, 2801-2810.
43. Siesje, B. K. Pathophysiology and treatment of focal cerebral ischaemia. Part II: Mechanism of damage and treatment. J. Neurosurg. 1992, 77, 337-354.